- Home
- NDLS vs ANEB Comparison
NDLS vs ANEB Comparison
Compare NDLS & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- ANEB
- Stock Information
- Founded
- NDLS 1995
- ANEB 2020
- Country
- NDLS United States
- ANEB United States
- Employees
- NDLS N/A
- ANEB N/A
- Industry
- NDLS Restaurants
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- NDLS Consumer Discretionary
- ANEB Health Care
- Exchange
- NDLS Nasdaq
- ANEB Nasdaq
- Market Cap
- NDLS 33.2M
- ANEB 90.4M
- IPO Year
- NDLS 2013
- ANEB 2021
- Fundamental
- Price
- NDLS $0.67
- ANEB $2.46
- Analyst Decision
- NDLS Buy
- ANEB Buy
- Analyst Count
- NDLS 2
- ANEB 2
- Target Price
- NDLS $3.00
- ANEB $8.00
- AVG Volume (30 Days)
- NDLS 170.0K
- ANEB 126.8K
- Earning Date
- NDLS 11-05-2025
- ANEB 11-12-2025
- Dividend Yield
- NDLS N/A
- ANEB N/A
- EPS Growth
- NDLS N/A
- ANEB N/A
- EPS
- NDLS N/A
- ANEB N/A
- Revenue
- NDLS $494,752,000.00
- ANEB N/A
- Revenue This Year
- NDLS $1.19
- ANEB N/A
- Revenue Next Year
- NDLS N/A
- ANEB N/A
- P/E Ratio
- NDLS N/A
- ANEB N/A
- Revenue Growth
- NDLS N/A
- ANEB N/A
- 52 Week Low
- NDLS $0.55
- ANEB $0.80
- 52 Week High
- NDLS $1.74
- ANEB $3.42
- Technical
- Relative Strength Index (RSI)
- NDLS 40.55
- ANEB 53.20
- Support Level
- NDLS $0.66
- ANEB $1.77
- Resistance Level
- NDLS $0.76
- ANEB $2.58
- Average True Range (ATR)
- NDLS 0.03
- ANEB 0.18
- MACD
- NDLS 0.00
- ANEB -0.03
- Stochastic Oscillator
- NDLS 18.18
- ANEB 61.06
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.